自免细胞疗法密集披露进展!最快明年 BLA,多家明星企业重点布局

医麦客
Oct 11

免费早鸟票,200 张限量领取2025 年 10 月 11 日医麦客新闻 eMedClub News10 月 9 日,合源生物自主研发的 HY001N 细胞注射液的 IND 已经获得 CDE 受理,拟用于治疗至少经过三线治疗失败的自身免疫性溶血性贫血(AIHA)患者。HY001N 细胞注射液是基于快速制备 NexT 技术平台开发的,减少了传统 CAR-T 细胞在体外的扩增培养操作步骤,使得 CAR...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10